Adastra Holdings Ltd. (XTXXF)
Adastra Holdings Ltd. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Langley, BC, CA. The stock last traded at $0.01, up 0.00% on the session, giving a market capitalisation of $39,179. On trailing twelve-month figures it carries a trailing P/E of -0.48, a net margin of -19.8%. Its beta of -0.51 implies it has historically moved less than the broad market.
Adastra Holdings Ltd. functions as a company specializing in cannabis extraction and processing. It offers services such as analytical testing for cannabis and comprehensive processing solutions. The firm supports authorized cannabis and hemp growers with its processing expertise and supplies concentrated cannabis derivatives to qualified business-to-business clients both domestically in Canada and worldwide. The company, which was established in 1987 and is headquartered in Langley, Canada, was formerly known as Phyto Extractions Inc. until it rebranded as Adastra Holdings Ltd. in September 2021.
Adastra Holdings Ltd. is most often compared with the following Healthcare names: